The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Open accessAbstract
Activation of nuclear factor (NF)-κB, one of the most investigated transcription factors, has been found to control multiple cellular processes in cancer including inflammation, transformation, proliferation, angiogenesis, invasion, metastasis, chemoresistance and radioresistance. NF-κB is constitutively active in most tumor cells, and its suppression inhibits the growth of tumor cells, leading to the concept of ‘NF-κB addiction’ in cancer cells. Why NF-κB is constitutively and persistently active in cancer cells is not fully understood, but multiple mechanisms have been delineated including agents that activate NF-κB (such as viruses, viral proteins, bacteria and cytokines), signaling intermediates (such as mutant receptors, overexpression of kinases, mutant oncoproteins, degradation of IκBα, histone deacetylase, overexpression of transglutaminase and iNOS) and cross talk between NF-κB and other transcription factors (such as STAT3, HIF-1α, AP1, SP, p53, PPARγ, β-catenin, AR, GR and ER). As NF-κB is ‘pre-active’ in cancer cells through unrelated mechanisms, classic inhibitors of NF-κB (for example, bortezomib) are unlikely to mediate their anticancer effects through suppression of NF-κB. This review discusses multiple mechanisms of NF-κB activation and their regulation by multitargeted agents in contrast to monotargeted agents, thus ‘one size does not fit all’ cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Anand, P., Kunnumakkara, A. B., Harikumar, K. B., Ahn, K. S., Badmaev, V., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1902 · Cited by 63
Self-citationRetractedInitial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 2×
“Mammalian NF-kB is a family of transcription factors that includes five members: RelA/p65, c-Rel, RelB, NF-kB1 (p50) and NF-kB2 (p52) (Ghosh and Karin, 2002; Vallabhapurapu and Karin, 2009).”
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 2×
“…addiction) It has become increasingly clear that besides having a role in regulating adaptive immune response, NF-kB signaling also has a critical role in cancer development and progression (Aggarwal, 2004; Basseres and Baldwin, 2006; Karin, 2006; Mantovani et al., 2008; Prasad et al., 2010).”
BackgroundThe Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696 · cited 3×
“…of breast, colorectal, pancreatic and brain cancers have revealed that cancer genomes are highly complex (Bignell et al., 2010; Ding et al., 2010; Pleasance et al., 2010a), with a range of 48–101 somatic alterations in each tumor, depending on the cancer type (Jones et al., 2008; Parsons et al.,…”
BackgroundAggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Self-citationIntegrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Self-citationActivation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Shaping the nuclear action of NF-κB
Chen, L.-F., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,221
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., Jones, D., Lin, M.-L., Beare, D., Lau, K. W., Greenman, C., et al. (2010) · Nature · doi:10.1038/nature08629 · Cited by 1,066
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity
Chen, Z. J., Parent, L., & Maniatis, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81064-8 · Cited by 951
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Chen, Z. J., & Sun, L. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.014 · Cited by 923
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
The IKK Complex, a Central Regulator of NF- B Activation
Israel, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 849
Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB
Chen, L., Mu, Y., & Greene, W. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf660 · Cited by 827
NF- B as a Critical Link Between Inflammation and Cancer
Karin, M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000141 · Cited by 816
Intragenic ERBB2 kinase mutations in tumours
Stephens, P., Hunter, C., Bignell, G., Edkins, S., Davies, H., Teague, J., Stevens, C., O'Meara, S., Smith, R., Parker, A., et al. (2004) · Nature · doi:10.1038/431525b · Cited by 802
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Self-citationVermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Ashburner, B. P., Westerheide, S. D., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7065-7077.2001 · Cited by 730
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 660
IκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 651
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Shembade, N., Ma, A., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 643
IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway
Lee, D.-F., Kuo, H.-P., Chen, C.-T., Hsu, J.-M., Chou, C.-K., Wei, Y., Sun, H.-L., Li, L.-Y., Ping, B., Huang, W.-C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.058 · Cited by 637
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 636
Ubiquitylation in innate and adaptive immunity
Bhoj, V. G., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature07959 · Cited by 634
Stein, B., Baldwin, A. S., Ballard, D. W., Greene, W. C., Angel, P., & Herrlich, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06066.x · Cited by 629
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene
Boehm, J. S., Zhao, J. J., Yao, J., Kim, S. Y., Firestein, R., Dunn, I. F., Sjostrom, S. K., Garraway, L. A., Weremowicz, S., Richardson, A. L., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.052 · Cited by 617
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sánchez‐Céspedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J. M., Westra, W. H., Herman, J. G., & Sidransky, D. (2002) · PubMed · Cited by 612
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
Self-citationMutations in the NF-κB signaling pathway: implications for human disease
Courtois, G., & Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209939 · Cited by 525
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 517
Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity
Werner, S. L., Barken, D., & Hoffmann, A. (2005) · Science · doi:10.1126/science.1113319 · Cited by 505
Sher, T., Dy, G. K., & Adjei, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.355 · Cited by 498
Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212389200 · Cited by 495
Self-citationStaudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., & Nabel, G. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06029.x · Cited by 484
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
Vereecke, L., Beyaert, R., & van Loo, G. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.007 · Cited by 482
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., Teague, J., Butler, A., Edkins, S., Stevens, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1855 · Cited by 469
Wang, D., Westerheide, S. D., Hanson, J. L., & Baldwin, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001358200 · Cited by 454
Profiling early head and neck cancer
Hunter, K. D., Parkinson, E. K., & Harrison, P. R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1549 · Cited by 437
Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals
AHN, K. S., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.026 · Cited by 432
Self-citationMorimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., Komeda, M., Fujita, M., Shimatsu, A., Kita, T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33160 · Cited by 423
Androgen receptor gene mutations in human prostate cancer.
Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., & Barrack, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6319 · Cited by 419
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Self-citationA requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Yang, S.-R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., & Rahman, I. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00308.2006 · Cited by 391
Dysregulated molecular networks in head and neck carcinogenesis
Molinolo, A. A., Amornphimoltham, P., Squarize, C. H., Castilho, R. M., Patel, V., & Gutkind, J. S. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.011 · Cited by 385
NF-κB and cancer: how intimate is this relationship
Prasad, S., Ravindran, J., & Aggarwal, B. B. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0267-2 · Cited by 385
Self-citationEarly signaling pathways activated by c-Kit in hematopoietic cells
Linnekin, D. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00078-3 · Cited by 385
Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., & Saiki, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301598200 · Cited by 377
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S.-Y., & Hung, M.-C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 372
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Hideshima, T., Ikeda, H., Chauhan, D., Okawa, Y., Raje, N., Podar, K., Mitsiades, C., Munshi, N. C., Richardson, P. G., Carrasco, R. D., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199604 · Cited by 363
Chung, S. W., Kang, B. Y., Kim, S. H., Pak, Y. K., Cho, D., Trinchieri, G., & Kim, T. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002577200 · Cited by 338
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202893 · Cited by 334
Essential role of RelA Ser311 phosphorylation by PKC in NF- B transcriptional activation
Duran, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg370 · Cited by 319
The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways
Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J., & Lin, R. (2007) · Nature Immunology · doi:10.1038/ni1465 · Cited by 318
Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2088 · Cited by 316
Self-citationCK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response
Kato, T., Delhase, M., Hoffmann, A., & Karin, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00358-7 · Cited by 314
Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-11-3550 · Cited by 306
Self-citationNormal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
Lennartsson, J., Jelacic, T., Linnekin, D., & Shivakrupa, R. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0117 · Cited by 303
Giri, D. K., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14008 · Cited by 299
Self-citationEstrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., & Kuehl, W. M. (2010) · Blood · doi:10.1182/blood-2009-09-243535 · Cited by 288
Missense mutations of the BRAF gene in human lung adenocarcinoma.
Naoki, K., Chen, T. H., Richards, W. G., Sugarbaker, D. J., & Meyerson, M. M. (2002) · PubMed · Cited by 287
Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65
Lu, T., Jackson, M. W., Wang, B., Yang, M., Chance, M. R., Miyagi, M., Gudkov, A. V., & Stark, G. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912493107 · Cited by 280
COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase
Maine, G. N., Mao, X., Komarck, C. M., & Burstein, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601489 · Cited by 278
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.-G., & Su, B. (2004) · Nature Immunology · doi:10.1038/ni1014 · Cited by 266
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., & Aggarwal, B. B. (2008) · Blood · doi:10.1182/blood-2007-10-117994 · Cited by 264
Self-citationBohuslav, J., Chen, L.-F., Kwon, H., Mu, Y., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313509200 · Cited by 256
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex
Kobori, M., Yang, Z., Gong, D., Heissmeyer, V, Zhu, H., Jung, Y.-K., Gakidis, M. A. M., Rao, A., Sekine, T., Ikegami, F., et al. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401325 · Cited by 249
A20: from ubiquitin editing to tumour suppression
Hymowitz, S. G., & Wertz, I. E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2775 · Cited by 247
Na, S.-Y., Kang, B. Y., Chung, S. W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J. W., & Kim, T. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7674 · Cited by 233
Hutti, J. E., Shen, R. R., Abbott, D. W., Zhou, A. Y., Sprott, K. M., Asara, J. M., Hahn, W. C., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.031 · Cited by 229
Integrin β4 signaling promotes tumor angiogenesis
Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., & Giancotti, F. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.029 · Cited by 220
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells
Cheng, P., Zlobin, A., Volgina, V., Gottipati, S., Osborne, B., Simel, E. J., Miele, L., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4458 · Cited by 216
Wolf, J., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., & Waes, C. V. (2001) · PubMed · Cited by 215
Mutual Transcriptional Interference between RelA and Androgen Receptor
Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 214
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Wang, H., Wang, H., Zhang, W., Huang, H. J., Liao, W. S. L., & Fuller, G. N. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700123 · Cited by 212
Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Lu, S.-L., Herrington, H., Reh, D., Weber, S., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1413306 · Cited by 204
Jackson-Bernitsas, D. G., Ichikawa, H., Takada, Y., Myers, J. N., Lin, X. L., Darnay, B. G., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Oncogene · doi:10.1038/sj.onc.1209945 · Cited by 203
Self-citationPandey, M. K., Sung, B., Kunnumakkara, A. B., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0511 · Cited by 200
Self-citationPark, K.-J., Krishnan, V., O’Malley, B. W., Yamamoto, Y., & Gaynor, R. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.006 · Cited by 193
Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions
Tang, X., Liu, D., Shishodia, S., Ozburn, N., Behrens, C., Lee, J. J., Hong, W. K., Aggarwal, B. B., & Wistuba, I. I. (2006) · Cancer · doi:10.1002/cncr.22315 · Cited by 190
Self-citationLim, C.-A., Yao, F., Wong, J. J.-Y., George, J., Xu, H., Chiu, K. P., Sung, W.-K., Lipovich, L., Vega, V. B., Chen, J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.038 · Cited by 190
Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
Bassères, D. S., Ebbs, A., Levantini, E., & Baldwin, A. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4290 · Cited by 189
MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor
Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., & Kufe, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0523 · Cited by 189
Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700890200 · Cited by 189
Self-citationIκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300
Hoberg, J. E., Popko, A. E., Ramsey, C. S., & Mayo, M. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.457-471.2006 · Cited by 181
The NF-κB-independent functions of IKK subunits in immunity and cancer
Chariot, A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.05.006 · Cited by 176
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Ahmad, R., Raina, D., Trivedi, V., Ren, J., Rajabi, H., Kharbanda, S., & Kufe, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1661 · Cited by 174
PLANAVILA, A., RODRIGUEZCALVO, R., JOVE, M., MICHALIK, L., WAHLI, W., LAGUNA, J., & VAZQUEZCARRERA, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.011 · Cited by 173
WIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer
Liptay, S., Weber, C. K., Ludwig, L., Wagner, M., Adler, G., & Schmid, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11081 · Cited by 172
Ge, J., Xu, H., Li, T., Zhou, Y., Zhang, Z., Li, S., Liu, L., & Shao, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907200106 · Cited by 172
Miyamoto, S., Chiao, P. J., & Verma, I. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3276 · Cited by 171
Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., & Aggarwal, B. B. (2009) · Blood · doi:10.1182/blood-2008-04-151944 · Cited by 167
Self-citationKumar, A., Lin, Z., SenBanerjee, S., & Jain, M. K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5893-5903.2005 · Cited by 165
Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in Inflammation
Reber, L. L., Vermeulen, L., Haegeman, G., & Frossard, N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004393 · Cited by 159
Schmitz, M. L., Stelzer, G., Altmann, H., Meisterernst, M., & Baeuerle, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7219 · Cited by 158
Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., & Arbeit, J. M. (2008) · Blood · doi:10.1182/blood-2007-10-115758 · Cited by 156
Gambaryan, S. P., Kobsar, A. L., Rukoyatkina, N., Herterich, S., Geiger, J., Smolenski, A., Lohmann, S. M., & Walter, U. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077602 · Cited by 155
Negative Regulation of NF-κB Signaling by PIAS1
Liu, B., Yang, R., Wong, K. A., Getman, C., Stein, N., Teitell, M. A., Cheng, G., Wu, H., & Shuai, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1113-1123.2005 · Cited by 153
Thomas, S. M., Bhola, N. E., Zhang, Q. H., Contrucci, S., Wentzel, A. L., Freilino, M. L., Gooding, W. E., Siegfried, J. M., Chan, D. C. F., & Grandis, J. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2876 · Cited by 151
Functional Interplay between Acetylation and Methylation of the RelA Subunit of NF-κB
Yang, X., Tajkhorshid, E., & Chen, L. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01343-09 · Cited by 150
Cao, Y., Luo, J., & Karin, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706728104 · Cited by 149
The c-Rel transcription factor and B-cell proliferation: a deal with the devil
Gilmore, T. D., Kalaitzidis, D., Liang, M., & Starczynowski, D. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207410 · Cited by 147
Many faces of NF-κB signaling induced by genotoxic stress
Wu, Z., & Miyamoto, S. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0227-9 · Cited by 147
Birkenkamp, K. U., Geugien, M., Schepers, H., Westra, J. M., Lemmink, H. H., & Vellenga, E. (2003) · Leukemia · doi:10.1038/sj.leu.2403145 · Cited by 146
Shishodia, S., & Aggarwal, B. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0206 · Cited by 138
Self-citationYoshida, Y., Kumar, A., Koyama, Y., Peng, H., Arman, A., Boch, J. A., & Auron, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311498200 · Cited by 135
Computational identification of transcriptional regulatory elements in DNA sequence
GuhaThakurta, D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl372 · Cited by 135
FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation
Zhou, W. H., Cao, Q., Peng, Y. S., Zhang, Q.-J., Castrillón, D. H., DePinho, R. A., & Liu, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.049 · Cited by 134
Vitale-Cross, L. A., Amornphimoltham, P., Fisher, G. H., Molinolo, A., & Gutkind, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2623 · Cited by 133
GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelAPreprint
Mao, X., Gluck, N., Li, D., Maine, G. N., Li, H., Zaidi, I. W., Repaka, A., Mayo, M. W., & Burstein, E. (2009) · Genes & Development · doi:10.1101/gad.1748409 · Cited by 133
Lee, S., Kim, J.-H., Lee, Y. C., Cheong, J. H., & Lee, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12470 · Cited by 127
Our changing view of the genomic landscape of cancer
Bell, D. W. (2009) · The Journal of Pathology · doi:10.1002/path.2645 · Cited by 126
Singh, S., Darnay, B. G., & Aggarwal, B. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31049 · Cited by 122
Self-citationRole of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection
Fan, S., Gao, M., Meng, Q., Laterra, J., Symons, M. H., Coniglio, S. J., Pestell, R. G., Goldberg, I. D., & Rosen, E. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208327 · Cited by 118
Inhibition of the RelA(p65) NF-κB Subunit by Egr-1
Chapman, N., & Perkins, N. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4719 · Cited by 115
Wilson, W., & Baldwin, A. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1061 · Cited by 112
Jeong, S., Radonovich, M. F., Brady, J. N., & Pise-Masison, C. A. (2004) · Blood · doi:10.1182/blood-2003-12-4174 · Cited by 105
Sethi, G., Ahn, K. S., Chaturvedi, M., & Aggarwal, B. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210544 · Cited by 104
Self-citationJamaluddin, M., Tian, B., Boldogh, I. R., Garofalo, R. P., & Brasier, A. R. (2009) · Journal of Virology · doi:10.1128/jvi.01090-09 · Cited by 104
Big science: The cancer genome challenge
Ledford, H. K. (2010) · Nature · doi:10.1038/464972a · Cited by 104
Renner, F., Moreno, R., & Schmitz, M. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.018 · Cited by 104
Sgarbanti, M., Remoli, A. L., Marsili, G., Ridolfi, B., Borsetti, A., Perrotti, E., Orsatti, R., Ilari, R., Sernicola, L., Stellacci, E., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00599-07 · Cited by 103
Roukos, D. H. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.69 · Cited by 102
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
Yang, J., Splittgerber, R. C., Yull, F. E., Kantrow, S. M., Ayers, G. D., Karin, M., & Richmond, A. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 102
Salminen, A., Paimela, T., Suuronen, T., & Kaarniranta, K. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.12.017 · Cited by 101
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F. R., & Sun, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072694 · Cited by 99
Signal Transduction of Oncogenic Flt3
Choudhary, C., Müller‐Tidow, C., Berdel, W. E., & Serve, H. L. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05090 · Cited by 98
Gong, R., Rifai, A., Ge, Y., Chen, S., & Dworkin, L. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710396200 · Cited by 98
Patel, V., Rosenfeldt, H. M., Lyons, R., Servitja, J., Bustelo, X. R., Siroff, M., & Gutkind, J. S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm008 · Cited by 97
UV as an Amplifier Rather Than Inducer of NF-κB Activity
O'Dea, E. L., Kearns, J. D., & Hoffmann, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.017 · Cited by 96
Son, P.-S., Park, S., Na, H., Jue, D., Kim, S., & Surh, Y. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq099 · Cited by 94
Current and Future Utilization of Services From Medical Oncologists
Warren, J. L., Mariotto, A. B., Meekins, A., Topor, M. A., & Brown, M. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.6357 · Cited by 92
The Rel/NF-κB/IκB Signal Transduction Pathway and Cancer
Gilmore, T. D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_10 · Cited by 91
Neil, J. R., & Schiemann, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3094 · Cited by 83
Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications
Hideshima, T., Chauhan, D., Kiziltepe, T., Ikeda, H., Okawa, Y., Podar, K., Raje, N. S., Protopopov, A. I., Munshi, N. C., Richardson, P. G. G., et al. (2009) · Blood · doi:10.1182/blood-2008-06-161505 · Cited by 82
Benezra, M., Chevallier, N., Morrison, D. J., MacLachlan, T. K., El‐Deiry, W. S., & Licht, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303076200 · Cited by 78
The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer.
Gilmore, T. D. (2003) · PubMed · Cited by 74
Mukhopadhyay, A., Manna, S. K., & Aggarwal, B. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8549 · Cited by 72
Self-citationZhu, F., Xia, X., Liu, B., Shen, J., Hu, Y., Person, M. D., & Hu, Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.042 · Cited by 72
Arun, P., Brown, M. S., Ehsanian, R., Chen, Z., & Waes, C. V. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1352 · Cited by 72
High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancer
Jiang, R., Xia, Y., Li, J., Deng, L., Zhao, L., Shi, J., Wang, X., & Sun, B. (2009) · International Journal of Cancer · doi:10.1002/ijc.24854 · Cited by 70
Yu, Z., & Kone, B. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000114556.19556.f9 · Cited by 70
Contradictory functions of NF-κB in liver physiology and cancer
Vainer, G. W., Pikarsky, E., & Ben‐Neriah, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.016 · Cited by 69
EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells
Page, C. L., Koumakpayi, I. H., Lessard, L., Mes‐Masson, A., & Fred Saad, C. (2005) · The Prostate · doi:10.1002/pros.20234 · Cited by 66
Wieland, G. D., Nehmann, N., Müller, D., Eibel, H., Siebenlist, U. K., Sühnel, J., Zipfel, P. F., & Skerka, C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02445 · Cited by 65
Activation of the serum response factor by p65/NF‐kappaB.
Franzoso, G., Carlson, L. M., Brown, K., Daucher, M., Bressler, P. B., & Siebenlist, U. K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00706.x · Cited by 63
Sun, H., Yang, T.-W., Zang, W., & Wu, S. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0270 · Cited by 63
Epigenetic Inactivation of IκB Kinase-α in Oral Carcinomas and Tumor Progression
Maeda, G., Chiba, T., Kawashiri, S., Satoh, T., & Imai, K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0463 · Cited by 62
Cited by
Liu, B., Sun, L., Liu, Q., Gong, C., Yao, Y., Lv, X., Lin, L., Yao, H., Su, F., Li, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.004 · Cited by 908
C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., Thiruvenkatam, R., et al. (2014) · Nature · doi:10.1038/nature13109 · Cited by 670
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Metadata
- Authors
- Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B.
- Venue
- Oncogene
- Published
- 2010-12-20
- Volume
- 30
- Issue
- 14
- Pages
- 1615-1630
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2038713860
- Cited by
- 473
- References
- 230
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.